Aridis Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2019 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2019 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2023 was -12.3 %, a 92.6% increase year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Return On Assets for 2022 was -180 %, a 12.5% increase from 2021.
  • Aridis Pharmaceuticals, Inc. annual Return On Assets for 2021 was -206 %, a 55.5% decline from 2020.
  • Aridis Pharmaceuticals, Inc. annual Return On Assets for 2020 was -133 %, a 13.4% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -12.3 +153 +92.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -87 +108 +55.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -222 -26.7 -13.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -180 +25.8 +12.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -165 +58.4 +26.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -195 -24.3 -14.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -196 -51.1 -35.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -206 -73.6 -55.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -224 -113 -102% Jul 1, 2021 Sep 30, 2021
Q2 2021 -171 -77.3 -82.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -144 -32.2 -28.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -133 -15.6 -13.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -111 +1.64 +1.46% Jul 1, 2020 Sep 30, 2020
Q2 2020 -93.5 +15.5 +14.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -112 -28.9 -34.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -117 Oct 1, 2019 Dec 31, 2019
Q3 2019 -112 Jul 1, 2019 Sep 30, 2019
Q2 2019 -109 Apr 1, 2019 Jun 30, 2019
Q1 2019 -83.4 Jan 1, 2019 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.